India Gets Its First Nasal Covid Vaccine

Bharat Biotech’s COVID-19 recombinant nasal vaccine has been approved by the Ministry of Health’s Central Drugs Standard Control Organisation for primary immunisation of those aged 18 years and above in emergency situations.

Similar Snaps
  • 12
  • 0
Share
  • Details
  • Date Found Sep 08, 2022